spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
1h8y
Jmol
Contents
Protein chains
247 a.a. *
Ligands
MER ×2
SO4 ×4
Waters ×324
* Residue conservation analysis
PDB id:
1h8y
Name: Hydrolase
Title: Crystal structure of the class d beta-lactamase oxa-13 in complex with meropenem
Structure: Beta-lactamase. Chain: a, b. Synonym: beta-lactamase oxa-13. Engineered: yes. Other_details: there is an ester link between ser a 67 og and mer a 300 c7 and between ser b 67 og and mer b 300 c7
Source: Pseudomonas aeruginosa. Organism_taxid: 287. Strain: pae391. Gene: bla oxa-13. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Homo-Dimer (from PDB file)
Resolution:
2.00Å     R-factor:   0.204     R-free:   0.257
Authors: L.Pernot,F.Frenois,T.Rybkine,G.L'Hermite,S.Petrella, J.Delettre,V.Jarlier,E.Collatz,W.Sougakoff
Key ref:
L.Pernot et al. (2001). Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem. J Mol Biol, 310, 859-874. PubMed id: 11453693 DOI: 10.1006/jmbi.2001.4805
Date:
17-Feb-01     Release date:   12-Jul-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q51400  (Q51400_PSEAE) -  Beta-lactamase
Seq:
Struc:
266 a.a.
247 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     peptidoglycan-based cell wall biogenesis   2 terms 
  Biochemical function     penicillin binding     2 terms  

 

 
DOI no: 10.1006/jmbi.2001.4805 J Mol Biol 310:859-874 (2001)
PubMed id: 11453693  
 
 
Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
L.Pernot, F.Frénois, T.Rybkine, G.L'Hermite, S.Petrella, J.Delettré, V.Jarlier, E.Collatz, W.Sougakoff.
 
  ABSTRACT  
 
The therapeutic problems posed by class D beta-lactamases, a family of serine enzymes that hydrolyse beta-lactam antibiotics following an acylation-deacylation mechanism, are increased by the very low level of sensitivity of these enzymes to beta-lactamase inhibitors. To gain structural and mechanistic insights to aid the design of new inhibitors, we have determined the crystal structure of OXA-13 from Pseudomonas aeruginosa in the apo form and in complex with the carbapenem meropenem. The native form consisted of a dimer displaying an overall organisation similar to that found in the closely related enzyme OXA-10. In the acyl-enzyme complex, the positioning of the antibiotic appeared to be ensured mainly by (i) the covalent acyl bond and (ii) a strong salt-bridge involving the carboxylate moiety of the drug. Comparison of the structures of OXA-13 in the apo form and in complex with meropenem revealed an unsuspected flexibility in the region of the essential serine 115 residue, with possible consequences for the catalytic properties of the enzyme. In the apo form, the Ser115 side-chain is oriented outside the active site, whereas the general base Lys70 adopts a conformation that seems to be incompatible with the activation of the catalytic water molecule required for the deacylation step. In the OXA-13:meropenem complex, a 3.5 A movement of the backbone of the 114-116 loop towards the side-chain of Lys70 was observed, which seems to be driven by a displacement of the neighbouring 91-104 loop and which results in the repositioning of the side-chain hydroxyl group of Ser115 toward the catalytic centre. Concomitantly, the side-chain of Lys70 is forced to curve in the direction of the deacylating water molecule, which is then strongly bound and activated by this residue. However, a distance of ca 5 A separates the catalytic water molecule from the acyl carbonyl group of meropenem, a structural feature that accounts for the inhibition of OXA-13 by this drug. Finally, the low level of penicillinase activity revealed by the kinetic analysis of OXA-13 could be related to the specific presence in position 73 of a serine residue located close to the general base Lys70, which results in a decrease of the number of hydrogen-bonding interactions stabilising the catalytic water molecule.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Superposition of the protein folds of OXA-13 in the native form (green ribbon) and in complex with meropenem (red ribbon). Meropenem (stick representation) is in pink. Water molecules are depicted using red spheres. Hydrogen bonds are shown as green broken lines.
Figure 2.
Figure 2. (a) Superimposition of the active site of OXA-13 (CPK colours) to OXA-10 (in blue, PDB accession code 1FOF). The protein backbones are shown, with the residues of interest in stick form. Hydrogen bonds are depicted by green broken lines. In the OXA-13 model, oxygen atoms are coloured red, carbon atoms gray and nitrogen atoms blue. The water molecules (HOH) are indicated by red and blue spheres in OXA-13 and OXA-10, respectively. The sulfate ion found in the active site of OXA-13 is shown in yellow and red. (b) Detailed view of the superimposition of OXA-13 (CPK colours) and OXA-10 (PDB entry code 1FOF ; in blue) in the 70-73 region.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2001, 310, 859-874) copyright 2001.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20145076 J.D.Docquier, M.Benvenuti, V.Calderone, F.Giuliani, D.Kapetis, F.De Luca, G.M.Rossolini, and S.Mangani (2010).
Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates.
  Antimicrob Agents Chemother, 54, 2167-2174.
PDB code: 3if6
19925018 S.M.Drawz, M.Babic, C.R.Bethel, M.Taracila, A.M.Distler, C.Ori, E.Caselli, F.Prati, and R.A.Bonomo (2010).
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
  Biochemistry, 49, 329-340.  
20065329 S.M.Drawz, and R.A.Bonomo (2010).
Three decades of beta-lactamase inhibitors.
  Clin Microbiol Rev, 23, 160-201.  
19485421 K.D.Schneider, C.R.Bethel, A.M.Distler, A.M.Hujer, R.A.Bonomo, and D.A.Leonard (2009).
Mutation of the active site carboxy-lysine (K70) of OXA-1 beta-lactamase results in a deacylation-deficient enzyme.
  Biochemistry, 48, 6136-6145.  
19919101 K.D.Schneider, M.E.Karpen, R.A.Bonomo, D.A.Leonard, and R.A.Powers (2009).
The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem.
  Biochemistry, 48, 11840-11847.
PDB code: 3isg
18922024 M.Kalp, and P.R.Carey (2008).
Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.
  Biochemistry, 47, 11830-11837.  
17374723 E.Santillana, A.Beceiro, G.Bou, and A.Romero (2007).
Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.
  Proc Natl Acad Sci U S A, 104, 5354-5359.
PDB code: 2jc7
17077507 M.Hata, Y.Fujii, Y.Tanaka, H.Ishikawa, M.Ishii, S.Neya, M.Tsuda, and T.Hoshino (2006).
Substrate deacylation mechanisms of serine-beta-lactamases.
  Biol Pharm Bull, 29, 2151-2159.  
16262787 C.V.Gallant, C.Daniels, J.M.Leung, A.S.Ghosh, K.D.Young, L.P.Kotra, and L.L.Burrows (2005).
Common beta-lactamases inhibit bacterial biofilm formation.
  Mol Microbiol, 58, 1012-1024.  
16162506 S.Negoro, T.Ohki, N.Shibata, N.Mizuno, Y.Wakitani, J.Tsurukame, K.Matsumoto, I.Kawamoto, M.Takeo, and Y.Higuchi (2005).
X-ray crystallographic analysis of 6-aminohexanoate-dimer hydrolase: molecular basis for the birth of a nylon oligomer-degrading enzyme.
  J Biol Chem, 280, 39644-39652.  
15322076 M.S.Wilke, T.L.Hills, H.Z.Zhang, H.F.Chambers, and N.C.Strynadka (2004).
Crystal structures of the Apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus.
  J Biol Chem, 279, 47278-47287.
PDB codes: 1xa1 1xa7
15461559 N.H.Georgopapadakou (2004).
Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
  Expert Opin Investig Drugs, 13, 1307-1318.  
12936985 M.A.Toleman, K.Rolston, R.N.Jones, and T.R.Walsh (2003).
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.
  Antimicrob Agents Chemother, 47, 2859-2863.  
12627955 N.Rhazi, P.Charlier, D.Dehareng, D.Engher, M.Vermeire, J.M.Frère, M.Nguyen-Distèche, and E.Fonzé (2003).
Catalytic mechanism of the Streptomyces K15 DD-transpeptidase/penicillin-binding protein probed by site-directed mutagenesis and structural analysis.
  Biochemistry, 42, 2895-2906.
PDB codes: 1es2 1es3 1es4 1j9m
12493831 T.Sun, M.Nukaga, K.Mayama, E.H.Braswell, and J.R.Knox (2003).
Comparison of beta-lactamases of classes A and D: 1.5-A crystallographic structure of the class D OXA-1 oxacillinase.
  Protein Sci, 12, 82-91.
PDB code: 1m6k
11724923 D.Golemi, L.Maveyraud, S.Vakulenko, J.P.Samama, and S.Mobashery (2001).
Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases.
  Proc Natl Acad Sci U S A, 98, 14280-14285.
PDB codes: 1k54 1k55 1k56 1k57
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.